ENZ Enzo Biochem
- 1.090
- +0.020+1.87%
Enzo Biochem News
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ:PSMT) rose sharply in today's pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings
Enzo Biochem (NYSE:ENZ) Shareholders Have Endured a 69% Loss From Investing in the Stock Three Years Ago
Express News | Enzo Biochem Q2 EPS $(0.06) Up From $(0.23) YoY, Sales $8.55M
Enzo Biochem 2Q Loss $3.06M >ENZ
Enzo Biochem 2Q Loss $3.06M >ENZ
Enzo Biochem 2Q Rev $8.55M >ENZ
Enzo Biochem 2Q Rev $8.55M >ENZ
Press Release: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") tod
Enzo Biochem Executives Receive Raises and Equity Rewards
Enzo Biochem Reports Results of Its Annual Meeting of Shareholders and Officer Appointments
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024
Here's Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)
HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects HEICO Corporation (NYSE:HEI) to report quarte
Stocks to Watch: Arcutis Biotherapeutics, Minerva Surgical, Enzo Biochem
By Ben Glickman Arcutis Biotherapeutics received FDA approval for its Zoryve topical foam in the treatment of seborrheic dermatitis late Friday. The company said it plans to make the product widely a
Express News | Enzo Biochem Q1 EPS $(0.13) Up From $(0.22) YoY
Enzo Biochem 1Q Loss/Shr 13c >ENZ
Enzo Biochem 1Q Loss/Shr 13c >ENZ
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced financial results for the first quarter ended October 31, 2023. First Qua
Enzo Biochem GAAP EPS of $0.41
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced financial results for the fourth quarter ended July 31, 2023, and the fis
Steven J. Pully Appointed to Enzo Biochem's Board of Directors
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or "the Company"), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company's
Enzo Biochem Names Interim CEO
Enzo Biochem CEO Hamid Erfanian Resigns After Two Years
By Will Feuer Enzo Biochem Chief Executive Hamid Erfanian has resigned and left the company after about two years. Enzo said Chief Operating Officer Kara Cannon will step in as interim CEO. "Hamid
Enzo Biochem: Hamid Erfanian, CEO, Will Be Resigning His Seat on the Bd of Directors and Departing the Co Effective Sept 5 >ENZ
Enzo Biochem: Hamid Erfanian, CEO, Will Be Resigning His Seat on the Bd of Directors and Departing the Co Effective Sept 5 >ENZ
Analysis
Price Target
No Data
